Voloridge Investment Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 127,602 shares of ARWR stock, worth $2.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

127,602

Previous 109,530 16.5%

Holding current value

$2.49 Million

Previous $2.85 Million 13.21%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.36 - $29.54 $349,873 - $533,846	18,072 Added 16.5%	127,602 $2.47 Million
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $2.4 Million - $3.09 Million	109,530 New	109,530 $2.85 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $2.45 Million - $3.58 Million	115,372 New	115,372 $3.53 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $6.33 Million - $10.4 Million	-251,521 Reduced 71.31%	101,193 $3.61 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $5.1 Million - $8.29 Million	215,281 Added 156.64%	352,714 $8.96 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $1.69 Million - $2.44 Million	60,279 Added 78.13%	137,433 $5.57 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $5.51 Million - $8.98 Million	-185,824 Reduced 70.66%	77,154 $2.55 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $5.22 Million - $9.51 Million	187,943 Added 250.47%	262,978 $9.26 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $2.52 Million - $4.46 Million	63,672 Added 560.34%	75,035 $3.45 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $10.6 Million - $15.1 Million	-183,050 Reduced 94.16%	11,363 $753,000
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $1.53 Million - $2.23 Million	26,259 Added 15.62%	194,413 $12.1 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $10.2 Million - $14.9 Million	-164,891 Reduced 49.51%	168,154 $13.9 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $14.8 Million - $21.8 Million	240,690 Added 260.61%	333,045 $22.1 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $4.05 Million - $7.88 Million	92,355 New	92,355 $7.09 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $2.74 Million - $4.54 Million	-104,849 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $91,471 - $280,820	4,449 Added 4.43%	104,849 $3.02 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $2.83 Million - $7.33 Million	100,400 New	100,400 $6.37 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $1.41 Million - $1.88 Million	-53,790 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $579,146 - $957,602	-33,227 Reduced 38.18%	53,790 $1.43 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $1.05 Million - $1.76 Million	87,017 New	87,017 $1.6 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History